Each injectable material presents distinct removal challenges based on its physical properties, tissue interaction, and the granulomatous response it stimulates. Dr. Karamanoukian has developed specific removal protocols for each.
PMMA Microsphere Filler
Bellafill (Artefill / Artecoll)
Bellafill is an FDA-approved PMMA (polymethyl methacrylate) microsphere filler suspended in a bovine collagen gel — marketed as a permanent filler for nasolabial folds and acne scars. Its predecessors Artefill and Artecoll use the same PMMA microsphere technology under different brand names. The collagen carrier is absorbed by the body within weeks of injection, but the PMMA microspheres — ranging from 30–42 microns in diameter, specifically sized to prevent phagocytosis by individual macrophages — remain permanently in the tissue and stimulate a progressive foreign body granulomatous reaction that creates persistent, expanding nodularity months to years after injection.
Dr. Karamanoukian is recognized as a world authority on Bellafill, Artefill, and Artecoll removal — having performed open surgical excision, ultrasound-guided removal, and multimodal granuloma management for these materials from the nasolabial folds, nose, lips, cheeks, periorbital area, and forehead. His published blog cases on Bellafill removal are among the most comprehensive documentation of these procedures available online and have made Kare Plastic Surgery the destination practice for Bellafill removal patients from throughout the United States.
Liquid Silicone Injection
Liquid Silicone & Medical-Grade Silicone Oil
Liquid silicone — whether injected as industrial silicone, purported “medical grade” silicone oil, or the Dermagen and Bioplastique silicone preparations — is the most problematic injectable material in plastic surgery due to its biological properties: it does not form discrete granulomas that can be excised as a unit, but rather disperses through tissue planes, is transported by macrophages to regional lymph nodes, and stimulates a diffuse granulomatous siliconoma that is intimately adherent to all surrounding structures. The progressive, migratory nature of silicone disease means that the tissue affected grows over time and the surgical field for removal becomes progressively more complex and dangerous the longer the material has been in place.
Dr. Karamanoukian performs liquid silicone removal from the face, lips, nose, and body using the most conservative and anatomically precise dissection possible — removing the grossly visible silicone deposits and their granuloma capsules while meticulously preserving all identifiable neurovascular and lymphatic structures. Complete removal of dispersed liquid silicone is frequently not achievable — an honest assessment that Dr. Karamanoukian provides at every consultation — but meaningful reduction of the silicone burden and the active inflammatory tissue produces significant improvement in symptoms and halts the progressive disfigurement of untreated disease.
European Silicone Biopolymer
Dermagen & Bioplastique
Dermagen and Bioplastique are textured polysiloxane (silicone) biopolymer preparations developed in Europe and used for body augmentation and facial volume restoration in the 1990s and 2000s — marketed as alternatives to hyaluronic acid fillers with more durable results. Both contain silicone particles in a carrier gel, with Bioplastique specifically formulated as a cross-linked silicone in a polyvinylpyrrolidone (PVP) carrier that was supposed to be resorbed, leaving the silicone particles embedded in the tissue as a permanent augmentation.
The clinical problems with these materials follow the same pattern as other silicone-based injectables — progressive granuloma formation, nodularity, migration, and inflammatory response — but are compounded by the cross-linked and particulate nature of the silicone that makes it technically different from pure liquid silicone in its tissue encapsulation pattern. Dr. Karamanoukian has developed specific approaches to Dermagen and Bioplastique removal that address the particulate silicone complex while managing the PVP carrier degradation products that contribute to the inflammatory reaction around these materials.
South American Biopolymer
Biopolimero
Biopolimero — also known as Biopolimero Venezolano, biopolymer, or simply “el polimero” in Latin American communities — is an unregulated injectable substance widely used in Venezuela, Colombia, Brazil, Mexico, and throughout Latin America for body augmentation, particularly buttock and breast enlargement without surgery. The exact composition of biopolimero varies by the practitioner and source — it may contain silicone, mineral oil, industrial oils, acrylamide, or a mixture of undefined substances — and is almost universally injected by non-physician practitioners in clandestine settings using non-sterile technique and contaminated materials.
The consequences of biopolimero injection are devastating: severe local inflammatory reaction, abscess formation, skin ulceration and necrosis, septicemia from contamination, migration to the abdomen, pelvis, and lymph nodes, and the progressive disfiguring fibrosis that makes the affected body area unrecognizable compared to its pre-injection anatomy. Dr. Karamanoukian treats biopolimero patients from Los Angeles’s large Latin American community and from throughout Southern California, coordinating with infectious disease specialists when active infection is present and with vascular surgeons when lymphatic or vascular involvement requires subspecialty management beyond plastic surgery alone.
Permanent Injectables
Hydrogel, Bio-Alcamid & Industrial Oils
Bio-Alcamid is a polyalkylimide hydrogel that was marketed in Europe and Latin America as a removable permanent filler but has proven significantly more difficult to remove than its marketing suggested — the gel migrates away from the injection site, becomes colonized by biofilm bacteria producing chronic low-grade infections, and forms a fibrous capsule that is adherent to surrounding tissue. Industrial oils — baby oil, cooking oil, and transformer oil have all been injected for body augmentation in non-clinical settings — produce severe lipogranulomatous reactions that are among the most challenging tissue environments for surgical management in plastic surgery.
Dr. Karamanoukian evaluates patients with all categories of problematic permanent injectables and provides an honest assessment of what surgical intervention can realistically achieve for each specific material and each specific anatomical location — including the frank acknowledgment, when appropriate, that complete removal is not achievable and that the goal is maximal symptomatic relief and reduction of the active inflammatory burden rather than anatomical restoration to the pre-injection state.
Hyaluronic Acid reversal
Tyndall Effect, Migration HA Filler Complications
While hyaluronic acid (HA) fillers (Juvéderm, Restylane, Sculptra, Radiesse) are theoretically reversible with hyaluronidase, chronic overinjection of HA — particularly in the periorbital zone, lips, and nose — produces tissue stretching, delayed granuloma formation, the Tyndall effect (bluish discoloration from superficially placed HA), and nodularity that does not adequately respond to standard hyaluronidase treatment. Similarly, calcium hydroxylapatite (Radiesse) and poly-L-lactic acid (Sculptra) complications require specialized removal approaches beyond simple hyaluronidase injection.
Dr. Karamanoukian treats chronic HA complication cases with ultrasound-guided hyaluronidase injection at high concentrations, microcannula dissolution and aspiration, and surgical excision for refractory HA nodules and the Tyndall effect. His ultrasound-guided approach allows precise identification of filler deposits in the periorbital and perinasal zones where blind injection of high-concentration hyaluronidase risks vascular and neural injury.